High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.

Thangaraju Tamilvanan, Waheeta Hopper
Author Information
  1. Thangaraju Tamilvanan: Department of Bioinformatics, School of Bioengineering, Faculty of Engineering & Technology, SRM University, Kattankulathur, 603203, Tamil Nadu, India.

Abstract

Ebolavirus, a member of the Filoviridae family of negative-sense RNA viruses, causes severe haemorrhagic fever leading up to 90% lethality. Ebolavirus matrix protein VP40 is involved in the virus assembly and budding process. The RNA binding pocket of VP40 is considered as the drug target site for structure based drug design. High Throughput Virtual Screening and molecular docking studies were employed to find the suitable inhibitors against VP40. Ten compounds showing good glide score and glide energy as well as interaction with specific amino acid residues were short listed as drug leads. These small molecule inhibitors could be potent inhibitors for VP40 matrix protein by blocking virus assembly and budding process.

Keywords

References

  1. Vaccine. 2006 Apr 5;24(15):2975-86 [PMID: 16530297]
  2. Virology. 2001 Apr 25;283(1):1-6 [PMID: 11312656]
  3. J Infect Dis. 1999 Feb;179 Suppl 1:S224-34 [PMID: 9988188]
  4. Virology. 2001 Aug 1;286(2):384-90 [PMID: 11485406]
  5. J Virol. 2000 Sep;74(17):8127-34 [PMID: 10933723]
  6. Vaccine. 2001 Nov 12;20(3-4):586-93 [PMID: 11672925]
  7. EMBO J. 2000 Aug 15;19(16):4228-36 [PMID: 10944105]
  8. Virus Res. 2003 Apr;92(2):187-93 [PMID: 12686428]
  9. J Gen Virol. 1994 May;75 ( Pt 5):1031-42 [PMID: 8176365]
  10. Antiviral Res. 2003 Jan;57(1-2):53-60 [PMID: 12615303]
  11. J Virol. 2002 Apr;76(8):3952-64 [PMID: 11907235]
  12. Virology. 1998 Nov 10;251(1):28-37 [PMID: 9813200]
  13. J Virol. 1998 Oct;72(10):8413-9 [PMID: 9733895]
  14. Nature. 2000 Nov 30;408(6812):605-9 [PMID: 11117750]
  15. Structure. 2003 Apr;11(4):423-33 [PMID: 12679020]
  16. Antiviral Res. 2003 Mar;58(1):47-56 [PMID: 12719006]
  17. J Virol. 2001 Feb;75(3):1117-23 [PMID: 11152484]
  18. FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):27-31 [PMID: 14734183]
  19. PLoS Pathog. 2008 Nov;4(11):e1000212 [PMID: 19023410]
  20. J Mol Biol. 2000 Jun 30;300(1):103-12 [PMID: 10864502]
  21. J Virol. 2002 Sep;76(18):9176-85 [PMID: 12186901]
  22. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D266-8 [PMID: 15608193]
  23. Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 [PMID: 11259830]
  24. Vaccine. 2003 Sep 8;21(25-26):4071-80 [PMID: 12922144]
  25. Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 No 1):899-907 [PMID: 12037327]
  26. J Exp Med. 2002 Mar 4;195(5):593-602 [PMID: 11877482]
  27. Virus Res. 1995 Dec;39(2-3):129-50 [PMID: 8837880]
  28. J Virol. 1991 Mar;65(3):1057-65 [PMID: 1847435]
  29. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6 [PMID: 11095724]
  30. JAMA. 2002 May 8;287(18):2391-405 [PMID: 11988060]
  31. Antivir Chem Chemother. 2005;16(5):283-94 [PMID: 16245644]
  32. Vaccine. 2004 Sep 3;22(25-26):3495-502 [PMID: 15308377]
  33. Nat Med. 2001 Dec;7(12):1313-9 [PMID: 11726971]
  34. Antiviral Res. 2009 Sep;83(3):245-51 [PMID: 19523489]
  35. Nat Med. 2005 Jul;11(7):786-90 [PMID: 15937495]
  36. J Mol Biol. 2003 Feb 14;326(2):493-502 [PMID: 12559917]

Word Cloud

Created with Highcharts 10.0.0VP40EbolavirusmatrixproteinvirusdrugdockinginhibitorsRNAassemblybuddingprocessHighstudiesglidevirtualscreeningmemberFiloviridaefamilynegative-sensevirusescausesseverehaemorrhagicfeverleading90%lethalityinvolvedbindingpocketconsideredtargetsitestructurebaseddesignThroughputVirtualScreeningmolecularemployedfindsuitableTencompoundsshowinggoodscoreenergywellinteractionspecificaminoacidresiduesshortlistedleadssmallmoleculepotentblockingHigh-throughputvp40ebolathroughputMolecular

Similar Articles

Cited By